WO2002029054A1 - Nouvelle proteine, son procede de production et son utilisation - Google Patents

Nouvelle proteine, son procede de production et son utilisation Download PDF

Info

Publication number
WO2002029054A1
WO2002029054A1 PCT/JP2001/008744 JP0108744W WO0229054A1 WO 2002029054 A1 WO2002029054 A1 WO 2002029054A1 JP 0108744 W JP0108744 W JP 0108744W WO 0229054 A1 WO0229054 A1 WO 0229054A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
same
activity
producing
novel protein
Prior art date
Application number
PCT/JP2001/008744
Other languages
English (en)
French (fr)
Inventor
Takafumi Ishii
Eiji Sunahara
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Priority to AU2001294181A priority Critical patent/AU2001294181A1/en
Priority to CA002424777A priority patent/CA2424777A1/en
Priority to US10/398,471 priority patent/US20040038257A1/en
Priority to EP01974681A priority patent/EP1331269A4/en
Publication of WO2002029054A1 publication Critical patent/WO2002029054A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PCT/JP2001/008744 2000-10-05 2001-10-04 Nouvelle proteine, son procede de production et son utilisation WO2002029054A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2001294181A AU2001294181A1 (en) 2000-10-05 2001-10-04 Novel protein, process for producing the same and use thereof
CA002424777A CA2424777A1 (en) 2000-10-05 2001-10-04 Novel protein, process for producing the same and use thereof
US10/398,471 US20040038257A1 (en) 2000-10-05 2001-10-04 Novel protein, process for producing the same and use thereof
EP01974681A EP1331269A4 (en) 2000-10-05 2001-10-04 NEW PROTEIN, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2000-311715 2000-10-05
JP2000311715 2000-10-05
JP2000387771 2000-12-20
JP2000-387771 2000-12-20
JP2001-8897 2001-01-17
JP2001008897 2001-01-17

Publications (1)

Publication Number Publication Date
WO2002029054A1 true WO2002029054A1 (fr) 2002-04-11

Family

ID=27344914

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/008744 WO2002029054A1 (fr) 2000-10-05 2001-10-04 Nouvelle proteine, son procede de production et son utilisation

Country Status (5)

Country Link
US (1) US20040038257A1 (ja)
EP (1) EP1331269A4 (ja)
AU (1) AU2001294181A1 (ja)
CA (1) CA2424777A1 (ja)
WO (1) WO2002029054A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1903143A (zh) * 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 生物型人工血管及其制备方法
CN100482178C (zh) 2005-08-04 2009-04-29 广东冠昊生物科技有限公司 带生物膜的血管瘤夹

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1033401A2 (en) * 1999-02-26 2000-09-06 Genset Expressed sequence tags and encoded human proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815284D0 (en) * 1998-07-14 1998-09-09 Janssen Pharmaceutica Nv Cloning and characterisation of novel mammallian peptidases
US6387888B1 (en) * 1998-09-30 2002-05-14 American Foundation For Biological Research, Inc. Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen
AU2002224553A1 (en) * 2000-07-21 2002-02-05 Incyte Genomics, Inc. Human proteases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1033401A2 (en) * 1999-02-26 2000-09-06 Genset Expressed sequence tags and encoded human proteins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BONALDO M.F. ET AL.: "Normalization and subtraction: Two approaches to facilitate gene discovery", GENOME RES., vol. 6, no. 9, 1996, pages 791 - 806, XP002039972 *
CARTER R.E. ET AL.: "Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase", PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 749 - 753, XP002129304 *
MAHADEVAN D. ET AL.: "The extracellular regions of PSMA and the transferrin receptor contain an aminopeptidase domain: Implications for drug design", PROTEIN SCI., vol. 8, no. 11, 1999, pages 2546 - 2549, XP002907490 *
PANGALOS M.N. ET AL.: "Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity", J. BIOL. CHEM., vol. 274, no. 13, 1999, pages 8470 - 8483, XP002129305 *
PASQUALINI R. ET AL.: "Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis", CANCER RES., vol. 60, February 2000 (2000-02-01), pages 722 - 727, XP002180667 *

Also Published As

Publication number Publication date
EP1331269A4 (en) 2005-01-12
CA2424777A1 (en) 2003-04-01
US20040038257A1 (en) 2004-02-26
EP1331269A1 (en) 2003-07-30
AU2001294181A1 (en) 2002-04-15

Similar Documents

Publication Publication Date Title
JP2004504001A (ja) スプライソソーム媒介ｒｎａトランスースプライシングにおける使用のための方法及び組成物
WO2002031134A3 (en) Novel serine protease genes related to dppiv
AU735355C (en) Novel protein and method for producing the protein
EP1067182A8 (en) Secretory protein or membrane protein
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
JPH02501618A (ja) タンパク質の代謝的安定性を調節する方法
WO2003030821A3 (en) Albumin fusion proteins
WO2006028561A3 (en) Novel purified fabi polypeptides from fransicella tularensis
WO2007093848A3 (en) Crystalline enoyl-(acyl-carrier-protein) reductase from heliobacter pylori
WO2001096527A3 (en) Peptides with physiological activity
WO1998011234A3 (en) Human protein kinases
WO2002029054A1 (fr) Nouvelle proteine, son procede de production et son utilisation
AU5653294A (en) Use of a dna sequence coding for an oxalic acid degrading protein as a selection gene
WO2000008134A3 (en) HUMAN HtrA SERINE PROTEASE
WO2001064876A3 (en) Human schizophrenia gene
WO2002053581A3 (en) Spliceosome mediated rna trans-splicing
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
WO1999054436A3 (en) Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
WO2004111240A3 (de) Sequenz für die bacillomycind synthese in bacillus amyloliquefaciens fzb42
WO2001036478A3 (en) Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
EP1536010A4 (en) MEDICINES FOR THE PREVENTION AND TREATMENT OF CANCER
WO2003060516A1 (fr) Methode de criblage
CA2530731A1 (en) Peptide having apoptosis-inhibiting activity
WO1999055885A3 (en) Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2424777

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10398471

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001974681

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001974681

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001974681

Country of ref document: EP